ATC_code_H03 Knowpia

ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H03A Thyroid preparations edit

H03AA Thyroid hormones edit

H03AA01 Levothyroxine sodium

H03AA02 Liothyronine sodium

H03AA03 Combinations of levothyroxine and liothyronine

H03AA04 Tiratricol

H03AA05 Thyroid gland preparations

H03AA51 Levothyroxine sodium and iodine compounds

H03B Antithyroid preparations edit

H03BA Thiouracils edit

H03BA01 Methylthiouracil

H03BA02 Propylthiouracil

H03BA03 Benzylthiouracil

H03BB Sulphur-containing imidazole derivatives edit

H03BB01 Carbimazole

H03BB02 Thiamazole

H03BB52 Thiamazole, combinations

H03BC Perchlorates edit

H03BC01 Potassium perchlorate

H03BX Other antithyroid preparations edit

H03BX01 Diiodotyrosine

H03BX02 Dibromotyrosine

H03C Iodine therapy edit

H03CA Iodine therapy edit

References edit

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code H03". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QH03". WHO Collaborating Centre for Drug Statistics Methodology.